December 2023
1. LAMI K, Ota N, Yamaoka S, Bychkov A, et al
   Standardized Classification of Lung Adenocarcinoma Subtypes and Improvement of Grading Assessment Through Deep Learning.
   Am J Pathol. 2023;193:2066-2079.
   

   >> Share

   
   October 2023
2. ZHU D, Nie Y, Zhao Y, Chen X, et al
   RNF152 Suppresses Fatty Acid Oxidation and Metastasis of Lung Adenocarcinoma by Inhibiting IRAK1-Mediated AKR1B10 Expression.
   Am J Pathol. 2023;193:1603-1617.
   

   >> Share

   
   May 2023
3. PENG M, Hu Q, Wu Z, Wang B, et al
   Mutation of TP53 confers ferroptosis resistance in lung cancer through the FOXM1/MEF2C axis.
   Am J Pathol. 2023 May 24:S0002-9440(23)00173.
   

   >> Share

   
   January 2023
4. ZHANG H, Qureshi MA, Wahid M, Charifa A, et al
   Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial Intelligence.
   Am J Pathol. 2023;193:51-59.
   

   >> Share

   
   October 2022
5. ZHAI WY, Duan FF, Wang YZ, Wang JY, et al
   Integrative Analysis of Bioinformatics and Machine Learning Algorithms Identifies a Novel Diagnostic Model Based on Costimulatory Molecule for Predicting Immune Microenvironment Status in Lung Adenocarcinoma.
   Am J Pathol. 2022;192:1433-1447.
   

   >> Share

   
   August 2022
6. KANTARCI A, Kansal S, Hasturk H, Stephens D, et al
   Resolvin E1 Reduces Tumor Growth in a Xenograft Model of Lung Cancer.
   Am J Pathol. 2022 Aug 6. pii: S0002-9440(22)00215.
   

   >> Share

   
   June 2022
7. MASAWA M, Sato-Yazawa H, Kashiwagi K, Ishii J, et al
   REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma.
   Am J Pathol. 2022;192:847-861.
   

   >> Share

   
   
8. ZHOU Y, Chang M, Wang N, Zhuang Y, et al
   Phosphatidylserine-Specific Phospholipase A1 Limits Aggressiveness of Lung Adenocarcinoma by Lysophosphatidylserine and Protein Kinase A-Dependent Pathway.
   Am J Pathol. 2022;192:970-983.
   

   >> Share

   
   April 2022
9. PARK J, Cho HG, Park J, Lee G, et al
   Artificial Intelligence-Powered Hematoxylin and Eosin Analyzer Reveals Distinct Immunologic and Mutational Profiles among Immune Phenotypes in Non-Small-Cell Lung Cancer.
   Am J Pathol. 2022;192:701-711.
   

   >> Share

   
   December 2021
10. DEHKHARGHANIAN T, Rahnamayan S, Riasatian A, Bidgoli AA, et al
    Selection, Visualization, and Interpretation of Deep Features in Lung Adenocarcinoma and Squamous Cell Carcinoma.
    Am J Pathol. 2021;191:2172-2183.
    

    >> Share

    
    November 2021
11. KHADIRNAIKAR S, Chatterjee A, Shukla S
    Identification and Characterization of Senescence Phenotype in Lung Adenocarcinoma with High Drug Sensitivity.
    Am J Pathol. 2021;191:1966-1973.
    

    >> Share

    
    September 2021
12. WANG Y, Yan F, Nasar A, Chen ZS, et al
    CUL4(high) Lung Adenocarcinomas Are Dependent on the CUL4-p21 Ubiquitin Signaling for Proliferation and Survival.
    Am J Pathol. 2021;191:1638-1650.
    

    >> Share

    
    July 2021
13. GOERTZEN N, Pappesch R, Fassunke J, Bruning T, et al
    Quantum Cascade Laser-Based Infrared Imaging as a Label-Free and Automated Approach to Determine Mutations in Lung Adenocarcinoma.
    Am J Pathol. 2021;191:1269-1280.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share